Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
2001/03/13 - 2001/11/29
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Principles of method if other than guideline:
There were no deviations from protocol that were considered to have affected the validity of the study. However the following deviation occurred: Air exchange was maintained at a minimum of 15 air changes per hour, not a minimum of 12-15 air changes per hour as stated in the protocol.
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3-trimethoxysilylpropyl methacrylate
EC Number:
219-785-8
EC Name:
3-trimethoxysilylpropyl methacrylate
Cas Number:
2530-85-0
Molecular formula:
C10H20O5Si
IUPAC Name:
3-(Trimethoxysilyl)propyl 2-methylprop-2-enoate
Details on test material:
- Name of test material (as cited in study report): Dow Corning Z-6030

- Substance type: Alkoxy-Si

- Physical state: colourless liquid

- Storage condition of test material: room temperature

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS

- Source: Not stated.

- Age at study initiation: 8 to 11 weeks old

- Weight at study initiation: 206 to 237 g

- Housing: Individually housed in cages with wire mesh floors (39x39x20 cm)

- Diet: Standard laboratory diet (RM1(E) SQC, ad libitum

- Water: ad libitum

- Acclimation period: minimum of 7 days



ENVIRONMENTAL CONDITIONS

- Temperature (°C): 20.5 to 22°C

- Humidity (%): 35-48%

- Air changes (per hr): minimum of 15

- Photoperiod (hrs dark / hrs light): 12/12 (0600-1800h)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: none
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: 1.92 ml/kg bodyweight to achieve a total dosage of approximately 2000 mg/kg



CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: The dose level for the study was chosen in compliance with the study guidelines.
Doses:
2000 mg/kg
No. of animals per sex per dose:
3M, 3F
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days

- Frequency of observations and weighing: Animals were observed on at least two occasions during the first hour following dosing (ca. thirty minutes apart) and thereafter at approximately hourly intervals for the remainder of Day 1 (final observation at 16.00 or 16.20). On subsequent days animals were once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity of the clinical signs and time were recorded at each observation. Observations included potential changes in the skin, fur, eyes and mucous membranes, changes in respiratory, circulatory, autonomic, central nervous system, somatomotor activity and behaviour pattern. Particular attention was directed toward the observation of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The bodyweight of each rat was recorded on days 1 (prior to dosing), 8 and 15. Individual body weights were recorded and bodyweight changes and group means calculated.

- Necropsy of survivors performed: yes

- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: All animals were subjected to a macroscopic examination, which consisted of examination of the cranial, thoracic and abdominal cavities. The macroscopic appearance of all examined organs was recorded.
Statistics:
Group mean bodyweights were calculated using appropriate means (STRAND version 1.0). No other statistical analyses were carried out.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
There were no treatment related deaths during the study.
Clinical signs:
Salivation was seen in all females, immediately after dosing but no clinical signs were seen in males throughout the study. Recovery of the rats as judged by external appearance and behaviour, was complete within approximately one hour of dosing.
Body weight:
Low bodyweight gain was recorded for one female on Day 15. All other rats were considered to have achieved satisfactory bodyweight gains during the study.
Gross pathology:
There were no abnormalities observed among animals sacrificed at study termination.
Other findings:
No other findings were reported.

Any other information on results incl. tables

Under the conditions of this study, the acute LD50 of 3-trimethoxysilylpropyl methacrylate was determined to be greater than 2000 mg/kg body weight.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The acute lethal oral dose was determined to be >2000 mg/kg bw in a reliable study conducted according to the appropriate test protocol, and in compliance with GLP.